KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to $42.1 million.

  • Nektar Therapeutics' Cash from Financing Activities rose 1089723.08% to $141.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.0 million, marking a year-over-year increase of 237.66%. This contributed to the annual value of $42.1 million for FY2024, which is 140293.33% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Cash from Financing Activities of $42.1 million as of FY2024, which was up 140,293.33% from $30,000 recorded in FY2023.
  • In the past 5 years, Nektar Therapeutics' Cash from Financing Activities ranged from a high of $42.1 million in FY2024 and a low of -$80.4 million during FY2020.
  • In the last 3 years, Nektar Therapeutics' Cash from Financing Activities had a median value of $1.5 million in 2022 and averaged $14.6 million.
  • Per our database at Business Quant, Nektar Therapeutics' Cash from Financing Activities plummeted by 444.05% in 2020 and then skyrocketed by 140,293.33% in 2024.
  • Over the past 5 years, Nektar Therapeutics' Cash from Financing Activities (Yearly) stood at -$80.4 million in 2020, then soared by 145.10% to $36.2 million in 2021, then plummeted by 95.84% to $1.5 million in 2022, then tumbled by 98.01% to $30,000 in 2023, then surged by 140,293.33% to $42.1 million in 2024.